Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions
BIOCELL · 2025 · 1-10
DOI: 10.32604/biocell.2025.067216 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIOCELL, 2025. Verfasst von Sotirios Charalampos Diamantoudis und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 380 Literaturangaben.
Abstract (Originalsprache)
Hematological cancer stem cells (HCSCs) is a subpopulation of cells within hematological cancers that, through their characteristics, enhance malignancy and render their therapy more challenging. By uncovering the underlying ... | Find, read and cite all the research you need on Tech Science Press
Zitieren
APA
Diamantoudis, S. C., Miliotou, A. N., Galatou, E., Telliou, S., Sideris, K., Grigoriadis, N., & Vizirianakis, I. S. (2025). Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions. BIOCELL, 0(0), 1-10. https://doi.org/10.32604/biocell.2025.067216
Vancouver
Diamantoudis SC, Miliotou AN, Galatou E, Telliou S, Sideris K, Grigoriadis N, et al. Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions. BIOCELL. 2025;0(0):1-10. doi:10.32604/biocell.2025.067216
BibTeX
@article{Diamantoudis2025,
author = {Diamantoudis, Sotirios Charalampos and Miliotou, Androulla N. and Galatou, Eleftheria and Telliou, Stergiani and Sideris, Konstantinos and Grigoriadis, Nikolaos and Vizirianakis, Ioannis S.},
title = {Assessing the Hematological Cancer Stem Cell Landscape to Improve Immunotherapy Clinical Decisions},
journal = {BIOCELL},
year = {2025},
volume = {0},
number = {0},
pages = {1--10},
doi = {10.32604/biocell.2025.067216}
}
EUVIMED